{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:38:44Z","timestamp":1787794724705,"version":"build-2784847793"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019125","name":"National Institute of Pharmaceutical Education and Research, Ahmedabad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019125","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.lfs.2025.124038","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T05:49:39Z","timestamp":1761025779000},"page":"124038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["NETosis in diabetic kidney disease: Molecular mechanisms and therapeutic opportunities"],"prefix":"10.1016","volume":"382","author":[{"given":"Akash Kumar","family":"Mourya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhi Pradeep","family":"Churi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nangshanbok","family":"Wahlang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.lfs.2025.124038_bb0015","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.2337\/dci22-0027","article-title":"Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"45","author":"de Boer","year":"2022","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.lfs.2025.124038_bb0020","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nefroe.2021.05.003","article-title":"Renal replacement therapy in critically ill patients with acute kidney injury: 2020 nephrologist\u2019s perspective","volume":"41","author":"Valdenebro","year":"2021","journal-title":"Nefrolog\u00eda (Engl. Ed.)"},{"key":"10.1016\/j.lfs.2025.124038_bb0025","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1046\/j.1523-1755.63.s83.20.x","article-title":"Renal transplantation in developing countries","volume":"63","author":"Rizvi","year":"2003","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.lfs.2025.124038_bb0030","article-title":"Advanced glycation end products: sparking the development of diabetic vascular injury","volume":"114","author":"A","year":"2006","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.lfs.2025.124038_bb0035","article-title":"Advanced glycation end products, oxidative stress and diabetic nephropathy","volume":"3","author":"Y. S","year":"2010","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.lfs.2025.124038_bb0040","article-title":"Protein kinase C activation and the development of diabetic complications","volume":"47","author":"K.","year":"1998","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.lfs.2025.124038_bb0045","article-title":"Activation of protein kinase C isoforms and its impact on diabetic complications","volume":"106","author":"G. P","year":"2010","journal-title":"Circ. Res."},{"issue":"6865","key":"10.1016\/j.lfs.2025.124038_bb0050","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"M","year":"2001","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.lfs.2025.124038_bb0055","article-title":"Redox imbalance stress in diabetes mellitus: role of the polyol pathway","volume":"1","author":"Lj","year":"2018","journal-title":"Anim. Models Exp. Med."},{"key":"10.1016\/j.lfs.2025.124038_bb0060","article-title":"Diabetic nephropathy: an overview","volume":"2067","author":"Mk","year":"2020","journal-title":"Methods Mol. Biol. (Clifton, N.J.)"},{"issue":"6","key":"10.1016\/j.lfs.2025.124038_bb0065","article-title":"Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease","volume":"31","author":"Hm","year":"2010","journal-title":"Am. J. Nephrol."},{"issue":"3","key":"10.1016\/j.lfs.2025.124038_bb0070","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ki.1981.33","article-title":"Glomerular hemodynamics in experimental diabetes mellitus","volume":"19","author":"Hostetter","year":"1981","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.lfs.2025.124038_bb0075","article-title":"Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat","volume":"77","author":"S","year":"1986","journal-title":"J. Clin. Invest."},{"issue":"15","key":"10.1016\/j.lfs.2025.124038_bb0080","doi-asserted-by":"crossref","first-page":"7881","DOI":"10.3390\/ijms22157881","article-title":"TGF-beta as a master regulator of diabetic nephropathy","volume":"22","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2025.124038_bb0085","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Xm","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"10.1016\/j.lfs.2025.124038_bb0090","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00281-013-0384-6","article-title":"Molecular mechanisms regulating NETosis in infection and disease","volume":"35","author":"Branzk","year":"2013","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.lfs.2025.124038_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173206","article-title":"NADPH oxidase: a membrane-bound enzyme and its inhibitors in diabetic complications","volume":"881","author":"Laddha","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.lfs.2025.124038_bb0100","doi-asserted-by":"crossref","first-page":"15753","DOI":"10.1096\/fj.202000994RR","article-title":"The role of neutrophil extracellular traps and TLR signaling in skeletal muscle ischemia reperfusion injury","volume":"34","author":"Edwards","year":"2020","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.lfs.2025.124038_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022043","article-title":"PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection","volume":"6","author":"Hemmers","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2025.124038_bb0110","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40164-025-00670-3","article-title":"Exploring neutrophil extracellular traps: mechanisms of immune regulation and future therapeutic potential","volume":"14","author":"Gao","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.lfs.2025.124038_bb0115","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a037028","article-title":"Neutrophil extracellular traps in host defense","volume":"12","author":"Burgener","year":"2020","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2025.124038_bb0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.htct.2023.05.008","article-title":"Immunothrombosis and its underlying biological mechanisms","volume":"46","author":"De Nardi","year":"2024","journal-title":"Hematol. Transfus. Cell Ther."},{"key":"10.1016\/j.lfs.2025.124038_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1357967","article-title":"Neutrophil extracellular traps in bacterial infections and evasion strategies","volume":"15","author":"Baz","year":"2024","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.lfs.2025.124038_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000639","article-title":"Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans","volume":"5","author":"Urban","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.lfs.2025.124038_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113673","article-title":"Neutrophil extracellular DNA traps activate the TLR9 signaling pathway of pancreatic ductal epithelial cells in patients with type 2 autoimmune pancreatitis","volume":"144","author":"Li","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2025.124038_bb0140","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12974-025-03531-2","article-title":"TLR9\/NF-\u03baB-mediated dendritic cell activation by neutrophil extracellular traps drives pathogenesis in experimental cerebral malaria","volume":"22","author":"Yao","year":"2025","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.lfs.2025.124038_bb0145","series-title":"NETosis Contributes to the Pathogenesis of Diabetes and Its Complications","author":"Njeim","year":"2020"},{"issue":"4","key":"10.1016\/j.lfs.2025.124038_bb0150","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1046\/j.1523-1755.1998.00109.x","article-title":"Mechanisms through which high glucose concentration raises [Ca2+]i in renal proximal tubular cells","volume":"54","author":"Symonian","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2025.124038_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1202463","article-title":"Diabetes-associated neutrophil NETosis: pathogenesis and interventional target of diabetic complications","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"10","key":"10.1016\/j.lfs.2025.124038_bb0160","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1681\/ASN.2014070673","article-title":"Neutrophil extracellular trap-related extracellular histones cause vascular necrosis in severe GN","volume":"26","author":"Kumar","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2025.124038_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1253667","article-title":"NETosis: an emerging therapeutic target in renal diseases","volume":"14","author":"Juha","year":"2023","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.lfs.2025.124038_bb0170","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.2337\/db22-0153","article-title":"Neutrophil extracellular traps induce glomerular endothelial cell dysfunction and pyroptosis in diabetic kidney disease","volume":"71","author":"Zheng","year":"2022","journal-title":"Diabetes"},{"issue":"14","key":"10.1016\/j.lfs.2025.124038_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/nu14142965","article-title":"Neutrophil extracellular traps promote NLRP3 inflammasome activation and glomerular endothelial dysfunction in diabetic kidney disease","volume":"14","author":"Gupta","year":"2022","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.lfs.2025.124038_bb0180","doi-asserted-by":"crossref","first-page":"693","DOI":"10.21037\/atm-22-2382","article-title":"Midkine promotes kidney injury in diabetic kidney disease by increasing neutrophil extracellular traps formation","volume":"10","author":"Liu","year":"2022","journal-title":"Ann. Transl. Med."},{"issue":"8","key":"10.1016\/j.lfs.2025.124038_bb0185","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1681\/ASN.2015060676","article-title":"Caspase-1, but not caspase-3, promotes diabetic nephropathy","volume":"27","author":"Shahzad","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.lfs.2025.124038_bb0190","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/4815488","article-title":"NET-related gene as potential diagnostic biomarkers for diabetic tubulointerstitial injury","volume":"2024","author":"Liang","year":"2024","journal-title":"J. Diabetes Res."},{"issue":"35","key":"10.1016\/j.lfs.2025.124038_bb0195","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000034992","article-title":"Bioinformatics led discovery of biomarkers related to immune infiltration in diabetes nephropathy","volume":"102","author":"Wang","year":"2023","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.lfs.2025.124038_bb0200","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s13577-023-00905-7","article-title":"Neutrophil (dys)function due to altered immuno-metabolic axis in type 2 diabetes: implications in combating infections","volume":"36","author":"Thimmappa","year":"2023","journal-title":"Hum. Cell"},{"issue":"7","key":"10.1016\/j.lfs.2025.124038_bb0205","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.134796","article-title":"Neutrophil extracellular traps promote macrophage inflammation and impair atherosclerosis resolution in diabetic mice","volume":"5","author":"Josefs","year":"2020","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.lfs.2025.124038_bb0210","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2337\/db15-0863","article-title":"NETosis delays diabetic wound healing in mice and humans","volume":"65","author":"Fadini","year":"2016","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.lfs.2025.124038_bb0215","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ki.5000054","article-title":"Renal fibrosis: new insights into the pathogenesis and therapeutics","volume":"69","author":"Liu","year":"2006","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.lfs.2025.124038_bb0220","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4274\/jcrpe.galenos.2021.2020.0303","article-title":"Midkine: utility as a predictor of early diabetic nephropathy in children with type 1 diabetes mellitus","volume":"13","author":"Metwalley","year":"2021","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"issue":"1","key":"10.1016\/j.lfs.2025.124038_bb0225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2353\/ajpath.2006.050488","article-title":"Growth factor midkine is involved in the pathogenesis of diabetic nephropathy","volume":"168","author":"Kosugi","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.lfs.2025.124038_bb0230","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000444881","article-title":"Circulating neutrophil extracellular trap levels in well-controlled type 2 diabetes and pathway involved in their formation induced by high-dose glucose","volume":"83","author":"Miyoshi","year":"2016","journal-title":"Pathobiology"},{"issue":"3","key":"10.1016\/j.lfs.2025.124038_bb0235","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1139\/o96-038","article-title":"Prevention of early glomerulopathy with tolrestat in the streptozotocin-induced diabetic rat","volume":"74","author":"Donnelly","year":"1996","journal-title":"Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.lfs.2025.124038_bb0240","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41401-018-0043-5","article-title":"The aldose reductase inhibitor epalrestat exerts nephritic protection on diabetic nephropathy in db\/db mice through metabolic modulation","volume":"40","author":"He","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2025.124038_bb0245","article-title":"Role of reactive oxygen species in the pathogenesis of diabetic nephropathy","volume":"82","author":"H","year":"2008","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"11","key":"10.1016\/j.lfs.2025.124038_bb0250","article-title":"Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease","volume":"24","author":"S. K","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.lfs.2025.124038_bb0255","doi-asserted-by":"crossref","DOI":"10.1038\/srep36362","article-title":"Elevated homocysteine levels in type 2 diabetes induce constitutive neutrophil extracellular traps","volume":"6","author":"Joshi","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.lfs.2025.124038_bb0260","article-title":"Neutrophil extracellular trap-associated molecules: a review on their immunophysiological and inflammatory roles","volume":"41","author":"Au","year":"2022","journal-title":"Int. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2025.124038_bb0265","article-title":"NETs promote inflammatory injury by activating cGAS-STING pathway in acute lung injury","volume":"24","author":"Z. J","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2025.124038_bb0270","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.xkme.2020.10.005","article-title":"Diabetic kidney disease, endothelial damage, and podocyte-endothelial crosstalk","volume":"3","author":"Gil","year":"2021","journal-title":"Kidney Med."},{"key":"10.1016\/j.lfs.2025.124038_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.110379","article-title":"Dysregulation of neutrophil extracellular traps (NETs)-related genes in the pathogenesis of diabetic kidney disease - results from bioinformatics analysis and translational studies","volume":"268","author":"Xie","year":"2024","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.lfs.2025.124038_bb0280","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12933-017-0579-6","article-title":"Neutrophil gelatinase associated lipocalin (NGAL) is elevated in type 2 diabetics with carotid artery stenosis and reduced under metformin treatment","volume":"16","author":"Eilenberg","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.lfs.2025.124038_bb0285","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.clim.2018.10.003","article-title":"The relationship between autophagy, increased neutrophil extracellular traps formation and endothelial dysfunction in chronic kidney disease","volume":"197","author":"Kim","year":"2018","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.lfs.2025.124038_bb0290","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00592-014-0676-x","article-title":"NETosis is induced by high glucose and associated with type 2 diabetes","volume":"52","author":"Menegazzo","year":"2015","journal-title":"Acta Diabetol."},{"issue":"6","key":"10.1016\/j.lfs.2025.124038_bb0295","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1055\/s-0032-1331226","article-title":"Reduced blood leukocyte and neutrophil numbers in the pathogenesis of type 1 diabetes","volume":"45","author":"Harsunen","year":"2013","journal-title":"Horm. Metab. Res."},{"issue":"12","key":"10.1016\/j.lfs.2025.124038_bb0300","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.2337\/db14-0480","article-title":"Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with \u03b2-cell autoimmunity in patients with type 1 diabetes","volume":"63","author":"Wang","year":"2014","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.lfs.2025.124038_bb0305","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.2337\/db12-1345","article-title":"Reduction of circulating neutrophils precedes and accompanies type 1 diabetes","volume":"62","author":"Valle","year":"2013","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.lfs.2025.124038_bb0310","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nm.3887","article-title":"Diabetes primes neutrophils to undergo NETosis, which impairs wound healing","volume":"21","author":"Wong","year":"2015","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.lfs.2025.124038_bb0315","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00592-018-1129-8","article-title":"The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo","volume":"55","author":"Menegazzo","year":"2018","journal-title":"Acta Diabetol."},{"issue":"8","key":"10.1016\/j.lfs.2025.124038_bb0320","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.3390\/biomedicines12081907","article-title":"Higher circulating neutrophil counts is associated with increased risk of all-cause mortality and cardiovascular disease in patients with diabetic kidney disease","volume":"12","author":"Xie","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.lfs.2025.124038_bb0325","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12882-022-02794-8","article-title":"Targeting inflammation for the treatment of Diabetic Kidney Disease: a five-compartment mechanistic model","volume":"23","author":"Hofherr","year":"2022","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.lfs.2025.124038_bb0330","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1232790","article-title":"Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms","volume":"14","author":"Xu","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"10.1016\/j.lfs.2025.124038_bb0335","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1681\/ASN.2008050482","article-title":"Avosentan reduces albumin excretion in diabetics with macroalbuminuria","volume":"20","author":"Wenzel","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.lfs.2025.124038_bb0340","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000045906","article-title":"Effects of endothelin receptor antagonists on the progression of diabetic nephropathy","volume":"87","author":"Hocher","year":"2001","journal-title":"Nephron"},{"issue":"6","key":"10.1016\/j.lfs.2025.124038_bb0345","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2215\/CJN.0000000000000161","article-title":"Glycemic control and effects of canagliflozin in reducing albuminuria and eGFR: a post hoc analysis of the CREDENCE Trial","volume":"18","author":"Hoek","year":"2023","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.lfs.2025.124038_bb0350","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000364909","article-title":"Efficacy and safety of canagliflozin in patients with type 2 diabetes and stage 3 nephropathy","volume":"40","author":"Yamout","year":"2014","journal-title":"Am. J. Nephrol."},{"issue":"1","key":"10.1016\/j.lfs.2025.124038_bb0355","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3810\/pgm.2014.01.2720","article-title":"Urinary tract infection in randomized phase III studies of canagliflozin, a sodium glucose co-transporter 2 inhibitor","volume":"126","author":"Nicolle","year":"2014","journal-title":"Postgrad. Med."},{"issue":"4","key":"10.1016\/j.lfs.2025.124038_bb0360","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1105351","article-title":"Bardoxolone methyl and kidney function in CKD with type 2 diabetes","volume":"365","author":"Pergola","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.lfs.2025.124038_bb0365","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"Zeeuw","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2025.124038_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115032","article-title":"Current findings on the efficacy of incretin-based drugs for diabetic kidney disease: a narrative review","volume":"165","author":"Mima","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.lfs.2025.124038_bb0375","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s12020-024-03757-9","article-title":"Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future","volume":"84","author":"Caruso","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/j.lfs.2025.124038_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104778","article-title":"Liraglutide attenuates renal tubular ectopic lipid deposition in rats with diabetic nephropathy by inhibiting lipid synthesis and promoting lipolysis","volume":"156","author":"Su","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.lfs.2025.124038_bb0385","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1507\/endocrj.EJ16-0449","article-title":"Reduction of visceral fat by liraglutide is associated with ameliorations of hepatic steatosis, albuminuria, and micro-inflammation in type 2 diabetic patients with insulin treatment: a randomized control trial","volume":"64","author":"Bouchi","year":"2017","journal-title":"Endocr. J."},{"issue":"11","key":"10.1016\/j.lfs.2025.124038_bb0390","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S2213-8587(18)30268-7","article-title":"Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial","volume":"6","author":"Muskiet","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"23","key":"10.1016\/j.lfs.2025.124038_bb0395","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"Pfeffer","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.lfs.2025.124038_bb0400","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa0708379","article-title":"Aliskiren combined with losartan in type 2 diabetes and nephropathy","volume":"358","author":"Parving","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.lfs.2025.124038_bb0405","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.lfs.2025.124038_bb0410","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1161\/01.CIR.0000024416.33113.0A","article-title":"Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect","volume":"106","author":"Viberti","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.lfs.2025.124038_bb0415","first-page":"2784","article-title":"Sitagliptin ameliorates diabetic nephropathy by blocking TGF-\u03b21\/Smad signaling pathway","volume":"41","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"11","key":"10.1016\/j.lfs.2025.124038_bb0420","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/dom.12983","article-title":"Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: outcomes from TECOS","volume":"19","author":"Engel","year":"2017","journal-title":"Diabetes Obes. Metab."},{"issue":"3","key":"10.1016\/j.lfs.2025.124038_bb0425","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/jdi.12142","article-title":"Sitagliptin improves albuminuria in patients with type 2 diabetes mellitus","volume":"5","author":"Mori","year":"2014","journal-title":"J. Diabetes Investig."},{"issue":"6","key":"10.1016\/j.lfs.2025.124038_bb0430","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.nefroe.2020.12.001","article-title":"The effect of linagliptin on renal progression in type-2 diabetes mellitus patients with chronic kidney disease: A prospective randomized controlled study","volume":"40","author":"Yagoglu","year":"2020","journal-title":"Nefrolog\u00eda (English Edition)"},{"issue":"2","key":"10.1016\/j.lfs.2025.124038_bb0435","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1507\/endocrj.EJ13-0305","article-title":"DPP-4 inhibition with alogliptin on top of angiotensin II type 1 receptor blockade ameliorates albuminuria via up-regulation of SDF-1\u03b1 in type 2 diabetic patients with incipient nephropathy","volume":"61","author":"Fujita","year":"2014","journal-title":"Endocr. J."},{"issue":"1","key":"10.1016\/j.lfs.2025.124038_bb0440","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1523-1755.2005.00416.x","article-title":"A pilot randomized controlled trial of renal protection with pioglitazone in diabetic nephropathy","volume":"68","author":"Agarwal","year":"2005","journal-title":"Kidney Int."},{"issue":"7","key":"10.1016\/j.lfs.2025.124038_bb0445","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.2337\/diabetes.54.7.2206","article-title":"Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients","volume":"54","author":"Pistrosch","year":"2005","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.lfs.2025.124038_bb0450","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.dsx.2018.04.013","article-title":"Effect of pioglitazone on decreasing of proteinuria in type 2 diabetic patients with nephropathy","volume":"13","author":"Pourshabanan","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"issue":"12","key":"10.1016\/j.lfs.2025.124038_bb0455","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1182\/blood-2014-07-587709","article-title":"PAD4-deficiency does not affect bacteremia in polymicrobial sepsis and ameliorates endotoxemic shock","volume":"125","author":"Martinod","year":"2015","journal-title":"Blood"},{"issue":"37","key":"10.1016\/j.lfs.2025.124038_bb0460","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj2101","article-title":"Neutrophil extracellular traps enhance macrophage killing of bacterial pathogens","volume":"7","author":"Monteith","year":"2021","journal-title":"Sci. Adv."},{"issue":"11","key":"10.1016\/j.lfs.2025.124038_bb0465","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/s41419-021-04294-3","article-title":"The emerging roles of neutrophil extracellular traps in wound healing","volume":"12","author":"Zhu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.lfs.2025.124038_bb0470","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nm.3547","article-title":"Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines","volume":"20","author":"Schauer","year":"2014","journal-title":"Nat. Med."},{"issue":"17","key":"10.1016\/j.lfs.2025.124038_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713581","article-title":"The role of neutrophil extracellular traps (NETs) in the pathogenesis of systemic lupus erythematosus and antiphospholipid syndrome","volume":"24","author":"Reshetnyak","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2025.124038_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00060","article-title":"Dexamethasone inhibits S. aureus-induced neutrophil extracellular pathogen-killing mechanism, possibly through Toll-like receptor regulation","volume":"8","author":"Wan","year":"2017","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2025.124038_bb0485","article-title":"Cyclosporine for treating rheumatoid arthritis","volume":"1998","author":"Wells","year":"1998","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.lfs.2025.124038_bb0490","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ab.2016.05.003","article-title":"Different procedures of diphenyleneiodonium chloride addition affect neutrophil extracellular trap formation","volume":"509","author":"Ostafin","year":"2016","journal-title":"Anal. Biochem."},{"issue":"3","key":"10.1016\/j.lfs.2025.124038_bb0495","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.162","article-title":"Molecular mechanisms and therapeutic target of NETosis in diseases","volume":"3","author":"Huang","year":"2022","journal-title":"MedComm"},{"issue":"6","key":"10.1016\/j.lfs.2025.124038_bb0500","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1161\/CIRCRESAHA.114.303312","article-title":"Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis","volume":"114","author":"Knight","year":"2014","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.lfs.2025.124038_bb0505","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nchembio.1735","article-title":"Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation","volume":"11","author":"Lewis","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"7","key":"10.1016\/j.lfs.2025.124038_bb0510","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1158\/1535-7163.MCT-19-1020","article-title":"A novel peptidylarginine deiminase 4 (PAD4) inhibitor BMS-P5 blocks formation of neutrophil extracellular traps and delays progression of multiple myeloma","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer Ther."},{"issue":"26","key":"10.1016\/j.lfs.2025.124038_bb0515","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aar6689","article-title":"Gasdermin d plays a vital role in the generation of neutrophil extracellular traps","volume":"3","author":"Sollberger","year":"2018","journal-title":"Sci. Immunol."},{"issue":"25","key":"10.1016\/j.lfs.2025.124038_bb0520","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1182\/blood.2021011525","article-title":"Gasdermin D inhibition prevents multiple organ dysfunction during sepsis by blocking NET formation","volume":"138","author":"Silva","year":"2021","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.lfs.2025.124038_bb0525","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1681\/ASN.2019060618","article-title":"Therapeutic myeloperoxidase inhibition attenuates neutrophil activation, ANCA-mediated endothelial damage, and crescentic GN","volume":"31","author":"Antonelou","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2025.124038_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119836","article-title":"Inhibition of neutrophil elastase prevents neutrophil extracellular trap formation and rescues mice from endotoxic shock","volume":"238","author":"Okeke","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.lfs.2025.124038_bb0535","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1190177","article-title":"Who and how, DNA sensors in NETs-driven inflammation","volume":"14","author":"Aub\u00e9","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2025.124038_bb0540","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1191\/096120399678847380","article-title":"Recombinant human Dnase I (rhDNase) in patients with lupus nephritis","volume":"8","author":"Davis","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.lfs.2025.124038_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122526","article-title":"Development of a rectally administrable Dnase1 to treat septic shock by targeting NETs","volume":"342","author":"Kwak","year":"2024","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.lfs.2025.124038_bb0550","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028526","article-title":"Neutrophil elastase enhances sputum solubilization in cystic fibrosis patients receiving DNase therapy","volume":"6","author":"Papayannopoulos","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.lfs.2025.124038_bb0555","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.4049\/jimmunol.1201719","article-title":"Neutrophil extracellular traps (NETs): double-edged swords of innate immunity","volume":"189","author":"Kaplan","year":"2012","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2025.124038_bb0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032366","article-title":"Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones","volume":"7","author":"Saffarzadeh","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2025.124038_bb0565","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12950-024-00423-9","article-title":"Resolution of acute inflammation induced by monosodium urate crystals (MSU) through neutrophil extracellular trap-MSU aggregate-mediated negative signaling","volume":"21","author":"Lu","year":"2024","journal-title":"J. Inflamm. (Lond)"},{"key":"10.1016\/j.lfs.2025.124038_bb0570","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.freeradbiomed.2023.03.025","article-title":"New insight into the composition of extracellular traps released by macrophages exposed to different types of inducers","volume":"202","author":"Jensen","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2025.124038_bb0575","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3907147","article-title":"The interplay of reactive oxygen species, hypoxia, inflammation, and sirtuins in cancer initiation and progression","volume":"2016","author":"Tafani","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"10","key":"10.1016\/j.lfs.2025.124038_bb0580","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048111","article-title":"Cytokines induced neutrophil extracellular traps formation: implication for the inflammatory disease condition","volume":"7","author":"Keshari","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.lfs.2025.124038_bb0585","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nm1565","article-title":"Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood","volume":"13","author":"Clark","year":"2007","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.lfs.2025.124038_bb0590","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.chom.2012.05.015","article-title":"Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1","volume":"12","author":"Saitoh","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.lfs.2025.124038_bb0595","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.910908","article-title":"Impact of neutrophil extracellular traps on thrombosis formation: new findings and future perspective","volume":"12","author":"Zhou","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"12","key":"10.1016\/j.lfs.2025.124038_bb0600","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168647","article-title":"NETosis before and after hyperglycemic control in type 2 diabetes mellitus patients","volume":"11","author":"Carestia","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.lfs.2025.124038_bb0605","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.2337\/dc13-0323","article-title":"Linagliptin lowers albuminuria on top of recommended standard treatment in patients with type 2 diabetes and renal dysfunction","volume":"36","author":"Groop","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2025.124038_bb0610","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.ijbiomac.2019.11.031","article-title":"Novel polydatin-loaded chitosan nanoparticles for safe and efficient type 2 diabetes therapy: in silico, in vitro and in vivo approaches","volume":"154","author":"Abdel-Moneim","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"8","key":"10.1016\/j.lfs.2025.124038_bb0615","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1320009","article-title":"Pharmacological targeting of peptidylarginine deiminase 4 prevents cancer-associated kidney injury in mice","volume":"6","author":"Cedervall","year":"2017","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.lfs.2025.124038_bb0620","first-page":"189","article-title":"Vitamin D prevents endothelial damage induced by increased neutrophil extracellular traps formation in patients with systemic lupus erythematosus","volume":"46","author":"Handono","year":"2014","journal-title":"Acta Med. Indones."},{"issue":"10","key":"10.1016\/j.lfs.2025.124038_bb0625","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/cbic.201600650","article-title":"Tetrahydroisoquinolines: new inhibitors of neutrophil extracellular trap (NET) formation","volume":"18","author":"Martinez","year":"2017","journal-title":"ChemBioChem"},{"issue":"8","key":"10.1016\/j.lfs.2025.124038_bb0630","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1182\/blood.2021013422","article-title":"Resolvin T-series reduce neutrophil extracellular traps","volume":"139","author":"Chiang","year":"2022","journal-title":"Blood"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525006745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525006745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:57:47Z","timestamp":1773190667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525006745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":124,"alternative-id":["S0024320525006745"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.124038","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NETosis in diabetic kidney disease: Molecular mechanisms and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.124038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124038"}}